World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
40551
World Ranking
12938
National Ranking
6615

Overview

Paul E. Goss is affiliated with Harvard University in the United States. Their research primarily falls within the field of Medicine, with a focus on Oncology and related subfields such as Reproductive Medicine, Genetics, Cancer Research, and Statistics and Probability.

The topics of their work cover areas including ovarian cancer diagnosis and treatment, cancer risks and factors, global cancer incidence and screening, estrogen and related hormone effects, breast cancer treatment studies, statistical methods in clinical trials, and medical imaging techniques and applications.

Paul E. Goss has contributed to several publications, notably:

  • Panorama of Gynecologic Cancer in Brazil, 2020, JCO Global Oncology
  • Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole, 2024, Journal of Clinical Oncology
  • Adjunctive statistical standardization of quantitated adjuvant ER and PgR in CCTG MA.27., 2024, Journal of Clinical Oncology
  • Abstract P1-07-06: Adjunctive statistical standardization of quantitated adjuvant HER2 and very low statistically standardized HER2 in CCTG MA.27, 2025, Clinical Cancer Research

The venues in which Paul E. Goss frequently publishes include the Journal of Clinical Oncology, JCO Global Oncology, and Clinical Cancer Research.

Frequent co-authors collaborating with Paul E. Goss are:

  • Jane Bayani
  • Sandip Sengupta
  • Tammy Piper
  • Mary Anne Quintayo
  • Shakeel Virk

Best Publications

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

    Paul E. Goss;James N. Ingle;Silvana Martino;Nicholas J. Robert

  • Breast cancer in China

    Lei Fan;Lei Fan;Kathrin Strasser-Weippl;Jun Jie Li;Jun Jie Li;Jessica St Louis

  • Estrogen and the Risk of Breast Cancer

    Mark Clemons;Paul Goss

  • Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials

    Colin Baigent;N. Bhala;J. Emberson;A. Merhi

  • Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

    Paul E. Goss;James N. Ingle;Silvana Martino;Nicholas J. Robert

  • Exemestane for Breast-Cancer Prevention in Postmenopausal Women

    Paul E. Goss;James N. Ingle;José E. Alés-Martínez;Angela M. Cheung

  • Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years

    Paul E. Goss;James N. Ingle;Kathleen I. Pritchard;Nicholas J. Robert

  • Planning cancer control in Latin America and the Caribbean

    Paul E. Goss;Brittany L. Lee;Brittany L. Lee;Tanja Badovinac-Crnjevic;Kathrin Strasser-Weippl

  • Challenges to effective cancer control in China, India, and Russia

    Paul E. Goss;Kathrin Strasser-Weippl;Brittany L. Lee-Bychkovsky;Brittany L. Lee-Bychkovsky;Lei Fan;Lei Fan

  • Inhibitors of carbohydrate processing: A new class of anticancer agents.

    Paul E Goss;Michael A. Baker;Jeremy P. Carver;James W. Dennis

  • Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

    Ellen Warner;William Foulkes;Pamela Goodwin;Wendy Meschino

  • Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

    Nadine Tchen;Helen G. Juffs;Fiona P. Downie;Qi-Long Yi

  • Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population

    Dennis C Sgroi;Ivana Sestak;Jack Cuzick;Yi Zhang

  • Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled Trials: The Cross Trial Safety Analysis

    Scott D. Solomon;Janet Wittes;Peter V. Finn;Robert Fowler

  • Physical and Psychological Morbidity After Axillary Lymph Node Dissection for Breast Cancer

    Thomas F. Hack;Lorenzo Cohen;Joel Katz;Lynda S. Robson

  • TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

    Steven J. Isakoff;Erica L. Mayer;Lei He;Tiffany A. Traina

  • Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996.

    Paul E. Goss;Caroline Reid;Melania Pintilie;Ruth Lim

  • Dietary Flaxseed Alters Tumor Biological Markers in Postmenopausal Breast Cancer

    Lilian U. Thompson;Jian Min Chen;Tong Li;Kathrin Strasser-Weippl

  • Aromatase inhibitors in the treatment and prevention of breast cancer

    Paul E. Goss;Kathrin Strasser

Frequent Co-Authors

Kathleen I. Pritchard
Kathleen I. Pritchard University of Toronto
James N. Ingle
James N. Ingle Mayo Clinic
Dianne M. Finkelstein
Dianne M. Finkelstein Harvard University
Timothy J. Whelan
Timothy J. Whelan McMaster University
Karen A. Gelmon
Karen A. Gelmon University of British Columbia
Dennis C. Sgroi
Dennis C. Sgroi Harvard University
Dongsheng Tu
Dongsheng Tu Queen's University
Matthew J. Ellis
Matthew J. Ellis Baylor College of Medicine
Aman U. Buzdar
Aman U. Buzdar The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career doesn’t always require following the traditional path of becoming an MD. For those seeking flexibility or wanting to enter the workforce sooner, numerous related online degrees and career pathways are available.

Many students begin by looking into nursing. If you want a more accessible entry, check out the easiest rn program options that offer less competitive admissions. For those aiming to skip certain pre-admission exams, consider absn programs that don't require teas. These options can accelerate your transition into nursing.

Prefer a non-clinical healthcare role? Training in medical billing and coding is a great alternative, especially for those interested in healthcare administration and technology. Explore medical billing and coding schools that accept financial aid to find programs that support your educational journey.

For career advancement, consider a healthcare administration online degree. This field offers broad opportunities to lead and manage within healthcare systems.

Best Scientists Citing Paul E. Goss

Trending Scientists

Recently Published Articles